PubMed:12692653 / 883-1044 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T7","span":{"begin":0,"end":161},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":161},"obj":"Sentence"}],"text":"Groups of male and female F344/N rats and B6C3F1 mice were exposed to 1-amino-2,4-dibromoanthraquinone (87% to 97% pure) for 13 weeks or for 9, 15, or 24 months."}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T5","span":{"begin":0,"end":161},"obj":"DRI_Background"}],"text":"Groups of male and female F344/N rats and B6C3F1 mice were exposed to 1-amino-2,4-dibromoanthraquinone (87% to 97% pure) for 13 weeks or for 9, 15, or 24 months."}